Chromothriptic cure of WHIM syndrome

Cell

Volumn 160, Issue 4, 2015, Pages 686-699

  McDermott, David H ^a   Gao, Ji Liang ^a   Liu, Qian ^a   Siwicki, Marie ^a   Martens, Craig ^b   Jacobs, Paejonette ^a   Velez, Daniel ^a   Yim, Erin ^a   Bryke, Christine R ^c,j   Hsu, Nancy ^c,j   Dai, Zunyan ^c,k   Marquesen, Martha M ^a   Stregevsky, Elina ^a   Kwatemaa, Nana ^a   Theobald, Narda ^a   Long Priel, Debra A ^d   Pittaluga, Stefania ^e   Raffeld, Mark A ^e   Calvo, Katherine R ^f   Maric, Irina ^f   Desmond, Ronan ^g,h   Holmes, Kevin L ^a   Kuhns, Douglas B ^d   Balabanian, Karl ⁱ   Bachelerie, Françoise ⁱ   Porcella, Stephen F ^b   Malech, Harry L ^a   Murphy, Philip M ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h ADELAIDE AND MEATH HOSPITAL   (Ireland)

ⁱ Universite Paris Sud   (France)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; CXCR4 PROTEIN, MOUSE;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHROMOSOME 2; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOTHRIPSIS; CONTROLLED STUDY; CXCR4 GENE; CYTOGENETICS; DONOR; FEMALE; GAIN OF FUNCTION MUTATION; GENE; GENETIC ANALYSIS; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LEUKOCYTE; LYMPHOID CELL; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; WHIM SYNDROME; YOUNG ADULT; ANIMAL; CASE REPORT; CHROMOSOMAL INSTABILITY; DISEASE MODEL; GENETICS; HUMAN CHROMOSOME; LYMPHOCYTE; MALE; METABOLISM; MOSAICISM; MUTATION; VERRUCA VULGARIS;

MUS;

ANIMALS; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN; DISEASE MODELS, ANIMAL; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTES; MALE; MICE; MIDDLE AGED; MOSAICISM; MUTATION; MYELOID CELLS; RECEPTORS, CXCR4; REMISSION, SPONTANEOUS; WARTS;

EID: 84922758305     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.014     Document Type: Article

References (41)

1. O. Al Ustwani, R. Kurzrock, and M. Wetzler Genetics on a WHIM Br. J. Haematol. 164 2014 15 23
2. F. Bachelerie, A. Ben-Baruch, A.M. Burkhardt, C. Combadiere, J.M. Farber, G.J. Graham, R. Horuk, A.H. Sparre-Ulrich, M. Locati, and A.D. Luster International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors Pharmacol. Rev. 66 2014 1 79
3. K. Balabanian, E. Brotin, V. Biajoux, L. Bouchet-Delbos, E. Lainey, O. Fenneteau, D. Bonnet, L. Fiette, D. Emilie, and F. Bachelerie Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice Blood 119 2012 5722 5730
4. S. Beaussant Cohen, O. Fenneteau, E. Plouvier, P.S. Rohrlich, G. Daltroff, I. Plantier, A. Dupuy, D. Kerob, B. Beaupain, and P. Bordigoni Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry Orphanet J. Rare Dis. 7 2012 71
5. C.C. Bleul, R.C. Fuhlbrigge, J.M. Casasnovas, A. Aiuti, and T.A. Springer A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J. Exp. Med. 184 1996 1101 1109
6. H.E. Broxmeyer, S. Cooper, L. Kohli, G. Hangoc, Y. Lee, C. Mantel, D.W. Clapp, and C.H. Kim Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo J. Immunol. 170 2003 421 429
7. H.E. Broxmeyer, L. Kohli, C.H. Kim, Y. Lee, C. Mantel, S. Cooper, G. Hangoc, M. Shaheen, X. Li, and D.W. Clapp Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells J. Leukoc. Biol. 73 2003 630 638
8. H.E. Broxmeyer, C.M. Orschell, D.W. Clapp, G. Hangoc, S. Cooper, P.A. Plett, W.C. Liles, X. Li, B. Graham-Evans, and T.B. Campbell Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J. Exp. Med. 201 2005 1307 1318
9. G.A. Challen, D. Sun, M. Jeong, M. Luo, J. Jelinek, J.S. Berg, C. Bock, A. Vasanthakumar, H. Gu, and Y. Xi Dnmt3a is essential for hematopoietic stem cell differentiation Nat. Genet. 44 2012 23 31
10. D.C. Dale, A.A. Bolyard, M.L. Kelley, E.C. Westrup, V. Makaryan, A. Aprikyan, B. Wood, and F.J. Hsu The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome Blood 118 2011 4963 4966
11. A. Dar, O. Kollet, and T. Lapidot Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice Exp. Hematol. 34 2006 967 975
12. L. Dotta, L. Tassone, and R. Badolato Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome Curr. Mol. Med. 11 2011 317 325
13. B. Haribabu, R.M. Richardson, I. Fisher, S. Sozzani, S.C. Peiper, R. Horuk, H. Ali, and R. Snyderman Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization J. Biol. Chem. 272 1997 28726 28731
14. P.A. Hernandez, R.J. Gorlin, J.N. Lukens, S. Taniuchi, J. Bohinjec, F. Francois, M.E. Klotman, and G.A. Diaz Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease Nat. Genet. 34 2003 70 74
15. R. Hirschhorn In vivo reversion to normal of inherited mutations in humans J. Med. Genet. 40 2003 721 728
16. M.J. Jones, and P.V. Jallepalli Chromothripsis: chromosomes in crisis Dev. Cell 23 2012 908 917
17. T. Kawai, and H.L. Malech WHIM syndrome: congenital immune deficiency disease Curr. Opin. Hematol. 16 2009 20 26
18. T. Kawai, U. Choi, L. Cardwell, S.S. DeRavin, N. Naumann, N.L. Whiting-Theobald, G.F. Linton, J. Moon, P.M. Murphy, and H.L. Malech WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4 Blood 109 2007 78 84
19. W.P. Kloosterman, V. Guryev, M. van Roosmalen, K.J. Duran, E. de Bruijn, S.C. Bakker, T. Letteboer, B. van Nesselrooij, R. Hochstenbach, M. Poot, and E. Cuppen Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline Hum. Mol. Genet. 20 2011 1916 1924
20. J.O. Korbel, and P.J. Campbell Criteria for inference of chromothripsis in cancer genomes Cell 152 2013 1226 1236
21. C.E. Krill Jr., H.D. Smith, and A.M. Mauer Chronic idiopathic granulocytopenia N. Engl. J. Med. 270 1964 973 979
22. E. Laurenti, B. Varnum-Finney, A. Wilson, I. Ferrero, W.E. Blanco-Bose, A. Ehninger, P.S. Knoepfler, P.F. Cheng, H.R. MacDonald, and R.N. Eisenman Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity Cell Stem Cell 3 2008 611 624
23. D.H. McDermott, Q. Liu, J. Ulrick, N. Kwatemaa, S. Anaya-O'Brien, S.R. Penzak, J.O. Filho, D.A. Priel, C. Kelly, and M. Garofalo The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome Blood 118 2011 4957 4962
24. D.H. McDermott, Q. Liu, D. Velez, L. Lopez, S. Anaya-O'Brien, J. Ulrick, N. Kwatemaa, J. Starling, T.A. Fleisher, and D.A. Priel A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor Blood 123 2014 2308 2316
25. Y. Nie, Y.C. Han, and Y.R. Zou CXCR4 is required for the quiescence of primitive hematopoietic cells J. Exp. Med. 205 2008 777 783
26. C. Orelio, M. Peeters, E. Haak, K. van der Horn, and E. Dzierzak Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver Haematologica 94 2009 462 469
27. N. Signoret, M.M. Rosenkilde, P.J. Klasse, T.W. Schwartz, M.H. Malim, J.A. Hoxie, and M. Marsh Differential regulation of CXCR4 and CCR5 endocytosis J. Cell Sci. 111 1998 2819 2830
28. P.J. Stephens, C.D. Greenman, B. Fu, F. Yang, G.R. Bignell, L.J. Mudie, E.D. Pleasance, K.W. Lau, D. Beare, and L.A. Stebbings Massive genomic rearrangement acquired in a single catastrophic event during cancer development Cell 144 2011 27 40
29. T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches Immunity 25 2006 977 988
30. L. Tassone, L.D. Notarangelo, V. Bonomi, G. Savoldi, A. Sensi, A. Soresina, C.I. Smith, F. Porta, A. Plebani, and R. Badolato Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients J Allergy Clin. Immunol. 123 2009 1170 1173
31. S. Venkatesan, J.J. Rose, R. Lodge, P.M. Murphy, and J.F. Foley Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4 Mol. Biol. Cell 14 2003 3305 3324
32. M. Wetzler, M. Talpaz, E.S. Kleinerman, A. King, Y.O. Huh, J.U. Gutterman, and R. Kurzrock A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia Am. J. Med. 89 1990 663 672
33. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595 599
34. W.W. Zuelzer "Myelokathexis"-a New Form of Chronic Granulocytopenia. Report of a Case N. Engl. J. Med. 270 1964 699 704
35. D. Kim, G. Pertea, C. Trapnell, H. Pimentel, R. Kelley, and S.L. Salzberg TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions Genome Biol. 14 2013 R36
36. M. Krzywinski, J. Schein, I. Birol, J. Connors, R. Gascoyne, D. Horsman, S.J. Jones, and M.A. Marra Circos: an information aesthetic for comparative genomics Genome Res. 19 2009 1639 1645
37. L.C. Lawnicki, R.J. Rubocki, W.C. Chan, D.M. Lytle, and T.C. Greiner The distribution of gene segments in T-cell receptor gamma gene rearrangements demonstrates the need for multiple primer sets J. Mol. Diagn. 5 2003 82 87
38. A. Mayle, M. Luo, M. Jeong, and M.A. Goodell Flow cytometry analysis of murine hematopoietic stem cells Cytometry A 83 2013 27 37
39. I. Ramasamy, M. Brisco, and A. Morley Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms J. Clin. Pathol. 45 1992 770 775
40. J.T. Robinson, H. Thorvaldsdóttir, W. Winckler, M. Guttman, E.S. Lander, G. Getz, and J.P. Mesirov Integrative genomics viewer Nat. Biotechnol. 29 2011 24 26
41. J.J. van Dongen, A.W. Langerak, M. Brüggemann, P.A. Evans, M. Hummel, F.L. Lavender, E. Delabesse, F. Davi, E. Schuuring, and R. García-Sanz Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 2003 2257 2317